6.
Garcia-Tirado J, Corbett J, Boiroux D, Jorgensen J, Breton M
. Closed-Loop Control with Unannounced Exercise for Adults with Type 1 Diabetes using the Ensemble Model Predictive Control. J Process Control. 2020; 80:202-210.
PMC: 7437946.
DOI: 10.1016/j.jprocont.2019.05.017.
View
7.
Ashley B, Brown M, Park Y, Kuan S, Koh A
. Skin-inspired, open mesh electrochemical sensors for lactate and oxygen monitoring. Biosens Bioelectron. 2019; 132:343-351.
DOI: 10.1016/j.bios.2019.02.041.
View
8.
Rebec M, Cai K, Dutt-Ballerstadt R, Anderson E
. A Prospective Multicenter Clinical Performance Evaluation of the C-CGM System. J Diabetes Sci Technol. 2020; 16(2):390-396.
PMC: 8861779.
DOI: 10.1177/1932296820964574.
View
9.
Rodbard D
. Evaluating quality of glycemic control: graphical displays of hypo- and hyperglycemia, time in target range, and mean glucose. J Diabetes Sci Technol. 2014; 9(1):56-62.
PMC: 4495532.
DOI: 10.1177/1932296814551046.
View
10.
. Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2016; 40(1):155-157.
DOI: 10.2337/dc16-2215.
View
11.
Perez-Gandia C, Garcia-Saez G, Subias D, Rodriguez-Herrero A, Gomez E, Rigla M
. Decision Support in Diabetes Care: The Challenge of Supporting Patients in Their Daily Living Using a Mobile Glucose Predictor. J Diabetes Sci Technol. 2018; 12(2):243-250.
PMC: 5851238.
DOI: 10.1177/1932296818761457.
View
12.
Klonoff D, Evans M, Lane W, Kempe H, Renard E, DeVries J
. A randomized, multicentre trial evaluating the efficacy and safety of fast-acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5). Diabetes Obes Metab. 2018; 21(4):961-967.
PMC: 6590130.
DOI: 10.1111/dom.13610.
View
13.
Tyler N, Mosquera-Lopez C, Wilson L, Dodier R, Branigan D, Gabo V
. An artificial intelligence decision support system for the management of type 1 diabetes. Nat Metab. 2020; 2(7):612-619.
PMC: 7384292.
DOI: 10.1038/s42255-020-0212-y.
View
14.
Nimri R, Battelino T, Laffel L, Slover R, Schatz D, Weinzimer S
. Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes. Nat Med. 2020; 26(9):1380-1384.
DOI: 10.1038/s41591-020-1045-7.
View
15.
Heinemann L
. Continuous Glucose Monitoring (CGM) or Blood Glucose Monitoring (BGM): Interactions and Implications. J Diabetes Sci Technol. 2018; 12(4):873-879.
PMC: 6134292.
DOI: 10.1177/1932296818768834.
View
16.
Armstrong D, Lavery L
. Diabetic foot ulcers: prevention, diagnosis and classification. Am Fam Physician. 1998; 57(6):1325-32, 1337-8.
View
17.
Najafi B
. Post the Pandemic: How will COVID-19 Transform Diabetic Foot Disease Management?. J Diabetes Sci Technol. 2020; 14(4):764-766.
PMC: 7673145.
DOI: 10.1177/1932296820930290.
View
18.
Clarke W, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B
. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience. J Diabetes Sci Technol. 2010; 3(5):1031-8.
PMC: 2769907.
DOI: 10.1177/193229680900300506.
View
19.
Bode B, Clarke J, Johnson J
. Use of Decision Support Software to Titrate Multiple Daily Injections Yielded Sustained A1c Reductions After 1 Year. J Diabetes Sci Technol. 2017; 12(1):124-128.
PMC: 5761995.
DOI: 10.1177/1932296817747886.
View
20.
Koeslag J, Noakes T, Sloan A
. Post-exercise ketosis. J Physiol. 1980; 301:79-90.
PMC: 1279383.
DOI: 10.1113/jphysiol.1980.sp013190.
View